Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05084352 · ClinicalTrials.gov registry record
Real Time Vital Sign Assessment to Predict Neurological Decline After Traumatic Brain Injury
A clinical trial of Traumatic Brain Injury, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- 1,200
- Enrollment target
- 1
- Study location
NCT05084352: Recruiting study of Traumatic Brain Injury, sponsored by University of Maryland, Baltimore.
NCT05084352 is a study of Traumatic Brain Injury that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 1,200 participants, above the 270-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (344% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05084352, a study of Traumatic Brain Injury, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will look to validate predictive algorithms developed in a previous study where we collected relevant data from trauma registry and after using advanced signal-processing and machine-learning, determined prediction scores regarding neuroworsening and other outcomes following traumatic brain injury.
Primary Outcome
Neurological decline is defined as a worsening in neurological status determined by a 2 point decline GCS, pupillary change, radiographic worsening defined by Rotterdam score, need for neurological or neurosurgical intervention (eg. treatment of seizure, raised ICP, hematoma evacuation)
Conditions Studied
Study Locations (1)
Maryland
- University of Maryland Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2021-03-29 |
| Est. Completion | 2026-10-31 |
What NCT05084352 shows while recruiting
NCT05084352 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, above the 270-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (344% higher).
The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 0 interventions.
NCT05084352 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05084352 about?
NCT05084352 is a clinical study titled "Real Time Vital Sign Assessment to Predict Neurological Decline After Traumatic Brain Injury". This study will look to validate predictive algorithms developed in a previous study where we collected relevant data from trauma registry and after using advanced signal-processing and machine-learning, determined prediction scores regarding neuroworsening and other outcomes following traumatic bra...
What is the current status of trial NCT05084352?
This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2021-03-29. Estimated completion is 2026-10-31.
What conditions does trial NCT05084352 study?
This clinical trial studies the following conditions: Traumatic Brain Injury.
Who is sponsoring clinical trial NCT05084352?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05084352 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05084352's enrollment target sits among peer trials
1,200 8th of 171 higher than 164 of 171 other Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
RECRUITING
-
A Study to Evaluate the SENSE Device's Ability to Detect TBI
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI